The $1.5 million award is to evaluate the ability of NervGen’s NVG-291-R to accelerate and enhance restoration of function following peripheral nerve injury (PNI) The research is to support a… Read More
Knowledge Translation (KT) activities aim to close the gap between research and implementation by improving the use of research evidence in practice, policy and further research. Through our 2022 Convening… Read More
Represents second Phase 2 program for EP-104IAR, with initial data readout anticipated in H1, 2023- VICTORIA, BC, Oct. 12, 2022 — Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX), a… Read More
We are pleased to invite you to participate in the Women-led Cohort of the Trade Accelerator Program (TAP)! TAP is a 5-day program designed to help SMEs TAP into their… Read More
Broad and trusted portfolio of COVID-19 rapid tests feature innovative updates and enhanced performance, building on insights gained throughout the pandemic All tests now work seamlessly with navify® Pass, Roche’s… Read More
